Literature DB >> 9761515

Acute effects of haemodialysis on cutaneous microcirculation in patients with peripheral arterial occlusive disease.

T Weiss1, C Windthorst, C Weiss, J Kreuzer, J Bommer, W Kübler.   

Abstract

BACKGROUND: Peripheral arterial occlusive disease (PAOD) is an increasing problem in patients on maintenance haemodialysis. Alterations in microvascular perfusion accompany and complicate arteriosclerosis of large vessels and might contribute to the disease process. The aim of the study was to investigate the acute effects of haemodialysis on the cutaneous microcirculation in 26 patients with and without intermittent claudication.
METHODS: Cutaneous perfusion was assessed by measuring transcutaneous oxygen pressure (tcPO2) and skin temperature at the dorsum of the foot. After standardized cooling to 15 degrees C of a 2cm2 skin area, the time to reach baseline skin temperature was evaluated as an indirect parameter of reactive hyperaemia.
RESULTS: During haemodialysis, tcPO2 dropped significantly in both groups. The decrease in tcPO2 was more pronounced in patients with PAOD (20% vs 15% n.s.). The reactive hyperaemia response was reduced significantly in patients with intermittent claudication indicated by a prolonged time to reach baseline skin temperature after cooling. Values of tcPO2 and reactive hyperaemia did not reach baseline values at the end of haemodialysis in either group.
CONCLUSIONS: Nutritive skin perfusion is impaired during haemodialysis. These changes are more pronounced in patients with PAOD and persist after dialysis. These findings are relevant for the treatment of patients with vascular disease on maintenance haemodialysis.

Entities:  

Mesh:

Year:  1998        PMID: 9761515     DOI: 10.1093/ndt/13.9.2317

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

1.  Insight in human skin microcirculation using in vivo reflectance-mode confocal laser scanning microscopy.

Authors:  Mehmet Ali Altintas; A A Altintas; M Guggenheim; A E Steiert; M C Aust; A D Niederbichler; C Herold; P M Vogt
Journal:  J Digit Imaging       Date:  2009-06-10       Impact factor: 4.056

2.  Skin disorders in peritoneal dialysis patients: An underdiagnosed subject.

Authors:  Meltem Gursu; Sami Uzun; Derya Topcuoğlu; Leyli Kadriye Koc; Lamiye Yucel; Abdullah Sumnu; Egemen Cebeci; Oktay Ozkan; Ahmet Behlul; Leyla Koc; Savas Ozturk; Rumeyza Kazancioglu
Journal:  World J Nephrol       Date:  2016-07-06

3.  Changes in skeletal muscle microcirculation after a hemodialysis session correlates with adequacy of dialysis.

Authors:  Chrysoula Pipili; Eirini Grapsa; Elli-Sophia Tripodaki; Sophia Ioannidou; Christos Manetos; Maria Parisi; Serafim Nanas
Journal:  Int J Nephrol Renovasc Dis       Date:  2015-06-08

4.  Detection of microcirculatory impairment by transcutaneous oxymetry monitoring during hemodialysis: an observational study.

Authors:  Ygal Benhamou; Loic Begarin; Nathalie David; Nicole Cailleux; Catherine Bessin; Herve Lévesque; Stephane Edet
Journal:  BMC Nephrol       Date:  2014-01-08       Impact factor: 2.388

5.  Microcirculatory changes and skeletal muscle oxygenation measured at rest by non-infrared spectroscopy in patients with and without diabetes undergoing haemodialysis.

Authors:  Roberto Alberto De Blasi; Remo Luciani; Giorgio Punzo; Roberto Arcioni; Rocco Romano; Marta Boezi; Paolo Menè
Journal:  Crit Care       Date:  2009-11-30       Impact factor: 9.097

6.  Factors associated with foot ulceration and amputation in adults on dialysis: a cross-sectional observational study.

Authors:  Michelle R Kaminski; Anita Raspovic; Lawrence P McMahon; Katrina A Lambert; Bircan Erbas; Peter F Mount; Peter G Kerr; Karl B Landorf
Journal:  BMC Nephrol       Date:  2017-09-08       Impact factor: 2.388

7.  Risk factors for foot ulceration in adults with end-stage renal disease on dialysis: a prospective observational cohort study.

Authors:  Michelle R Kaminski; Katrina A Lambert; Anita Raspovic; Lawrence P McMahon; Bircan Erbas; Peter F Mount; Peter G Kerr; Karl B Landorf
Journal:  BMC Nephrol       Date:  2019-11-21       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.